Clinical Trial: A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets

U.S., June 17 -- ClinicalTrials.gov registry received information related to the study (NCT07652047) titled 'A Study to Evaluate the Safety and Tolerability of Different Doses of CX11 Tablets' on June 11.

Brief Summary: A multi-center, randomized, placebo-controlled, double-blinded (within cohorts), Sponsor-unblinded, Phase 1b study to explore the safety, pharmacokinetics, and pharmacodynamics of CX11 tablets in participants with obesity or overweight with weight-related comorbidities.

Study Start Date: May 11

Study Type: INTERVENTIONAL

Condition: Obesity & Overweight

Intervention: DRUG: CX11

CX11 tablets administered orally once daily (QD) with meals

OTHER: Placebo

Matching placebo tablets administered orally once daily (QD) with...